Microsoft Corporation
Microsoft Corporation (MSF.DE) Stock Competitors & Peer Comparison
See (MSF.DE) competitors and their performances in Stock Market.
Peer Comparison Table: Software - Infrastructure Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MSF.DE | €364.90 | +0.44% | 2.7T | 25.11 | €14.31 | +0.83% |
| MSF.F | €364.85 | +0.43% | 2.7T | 25.28 | €14.34 | +0.82% |
| ORC.DE | €156.84 | -6.01% | 460B | 33.60 | €4.76 | +1.07% |
| PTX.F | €115.70 | -0.60% | 263B | 150.74 | €0.76 | N/A |
| SYP.DE | €424.00 | -0.35% | 80.7B | 75.67 | €5.57 | N/A |
| BZF1.DE | €139.80 | -1.55% | 60.4B | 45.99 | €3.04 | N/A |
| SQ3.F | €61.25 | +0.74% | 36.1B | 55.69 | €1.09 | N/A |
| 1N8.DE | €950.20 | +6.90% | 28.9B | 27.24 | €33.60 | N/A |
| VRS.DE | €264.25 | +3.24% | 24B | 35.18 | €7.48 | +1.02% |
| FFV.DE | €297.70 | +0.40% | 17.4B | 53.83 | €5.53 | N/A |
Stock Comparison
MSF.DE vs MSF.F Comparison May 2026
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 2.7T. In comparison, MSF.F has a market cap of 2.7T. Regarding current trading prices, MSF.DE is priced at €364.90, while MSF.F trades at €364.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 25.11, whereas MSF.F's P/E ratio is 25.28. In terms of profitability, MSF.DE's ROE is +0.33%, compared to MSF.F's ROE of +0.33%. Regarding short-term risk, MSF.DE is less volatile compared to MSF.F. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check MSF.F's competition here
MSF.DE vs ORC.DE Comparison May 2026
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 2.7T. In comparison, ORC.DE has a market cap of 460B. Regarding current trading prices, MSF.DE is priced at €364.90, while ORC.DE trades at €156.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 25.11, whereas ORC.DE's P/E ratio is 33.60. In terms of profitability, MSF.DE's ROE is +0.33%, compared to ORC.DE's ROE of +0.57%. Regarding short-term risk, MSF.DE is less volatile compared to ORC.DE. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check ORC.DE's competition here
MSF.DE vs PTX.F Comparison May 2026
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 2.7T. In comparison, PTX.F has a market cap of 263B. Regarding current trading prices, MSF.DE is priced at €364.90, while PTX.F trades at €115.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 25.11, whereas PTX.F's P/E ratio is 150.74. In terms of profitability, MSF.DE's ROE is +0.33%, compared to PTX.F's ROE of +0.32%. Regarding short-term risk, MSF.DE is less volatile compared to PTX.F. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check PTX.F's competition here
MSF.DE vs SYP.DE Comparison May 2026
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 2.7T. In comparison, SYP.DE has a market cap of 80.7B. Regarding current trading prices, MSF.DE is priced at €364.90, while SYP.DE trades at €424.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 25.11, whereas SYP.DE's P/E ratio is 75.67. In terms of profitability, MSF.DE's ROE is +0.33%, compared to SYP.DE's ROE of +0.05%. Regarding short-term risk, MSF.DE is more volatile compared to SYP.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MSF.DE.Check SYP.DE's competition here
MSF.DE vs BZF1.DE Comparison May 2026
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 2.7T. In comparison, BZF1.DE has a market cap of 60.4B. Regarding current trading prices, MSF.DE is priced at €364.90, while BZF1.DE trades at €139.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 25.11, whereas BZF1.DE's P/E ratio is 45.99. In terms of profitability, MSF.DE's ROE is +0.33%, compared to BZF1.DE's ROE of +3.99%. Regarding short-term risk, MSF.DE is more volatile compared to BZF1.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MSF.DE.Check BZF1.DE's competition here
MSF.DE vs SQ3.F Comparison May 2026
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 2.7T. In comparison, SQ3.F has a market cap of 36.1B. Regarding current trading prices, MSF.DE is priced at €364.90, while SQ3.F trades at €61.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 25.11, whereas SQ3.F's P/E ratio is 55.69. In terms of profitability, MSF.DE's ROE is +0.33%, compared to SQ3.F's ROE of +0.04%. Regarding short-term risk, MSF.DE is more volatile compared to SQ3.F. This indicates potentially higher risk in terms of short-term price fluctuations for MSF.DE.Check SQ3.F's competition here
MSF.DE vs 1N8.DE Comparison May 2026
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 2.7T. In comparison, 1N8.DE has a market cap of 28.9B. Regarding current trading prices, MSF.DE is priced at €364.90, while 1N8.DE trades at €950.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 25.11, whereas 1N8.DE's P/E ratio is 27.24. In terms of profitability, MSF.DE's ROE is +0.33%, compared to 1N8.DE's ROE of +0.17%. Regarding short-term risk, MSF.DE is less volatile compared to 1N8.DE. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check 1N8.DE's competition here
MSF.DE vs VRS.DE Comparison May 2026
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 2.7T. In comparison, VRS.DE has a market cap of 24B. Regarding current trading prices, MSF.DE is priced at €364.90, while VRS.DE trades at €264.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 25.11, whereas VRS.DE's P/E ratio is 35.18. In terms of profitability, MSF.DE's ROE is +0.33%, compared to VRS.DE's ROE of -0.40%. Regarding short-term risk, MSF.DE is more volatile compared to VRS.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MSF.DE.Check VRS.DE's competition here
MSF.DE vs FFV.DE Comparison May 2026
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 2.7T. In comparison, FFV.DE has a market cap of 17.4B. Regarding current trading prices, MSF.DE is priced at €364.90, while FFV.DE trades at €297.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 25.11, whereas FFV.DE's P/E ratio is 53.83. In terms of profitability, MSF.DE's ROE is +0.33%, compared to FFV.DE's ROE of +0.15%. Regarding short-term risk, MSF.DE is more volatile compared to FFV.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MSF.DE.Check FFV.DE's competition here
MSF.DE vs KKS.F Comparison May 2026
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 2.7T. In comparison, KKS.F has a market cap of 14.4B. Regarding current trading prices, MSF.DE is priced at €364.90, while KKS.F trades at €75.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 25.11, whereas KKS.F's P/E ratio is 8.10. In terms of profitability, MSF.DE's ROE is +0.33%, compared to KKS.F's ROE of +0.45%. Regarding short-term risk, MSF.DE is more volatile compared to KKS.F. This indicates potentially higher risk in terms of short-term price fluctuations for MSF.DE.Check KKS.F's competition here
MSF.DE vs AK3.DE Comparison May 2026
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 2.7T. In comparison, AK3.DE has a market cap of 14.4B. Regarding current trading prices, MSF.DE is priced at €364.90, while AK3.DE trades at €95.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 25.11, whereas AK3.DE's P/E ratio is 31.55. In terms of profitability, MSF.DE's ROE is +0.33%, compared to AK3.DE's ROE of +0.08%. Regarding short-term risk, MSF.DE is more volatile compared to AK3.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MSF.DE.Check AK3.DE's competition here
MSF.DE vs IOS.DE Comparison May 2026
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 2.7T. In comparison, IOS.DE has a market cap of 4B. Regarding current trading prices, MSF.DE is priced at €364.90, while IOS.DE trades at €29.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 25.11, whereas IOS.DE's P/E ratio is 18.69. In terms of profitability, MSF.DE's ROE is +0.33%, compared to IOS.DE's ROE of +0.84%. Regarding short-term risk, MSF.DE is less volatile compared to IOS.DE. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check IOS.DE's competition here
MSF.DE vs 3L7A.F Comparison May 2026
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 2.7T. In comparison, 3L7A.F has a market cap of 2.9B. Regarding current trading prices, MSF.DE is priced at €364.90, while 3L7A.F trades at €86.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 25.11, whereas 3L7A.F's P/E ratio is 17.57. In terms of profitability, MSF.DE's ROE is +0.33%, compared to 3L7A.F's ROE of +0.37%. Regarding short-term risk, MSF.DE is less volatile compared to 3L7A.F. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check 3L7A.F's competition here
MSF.DE vs SOW.DE Comparison May 2026
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 2.7T. In comparison, SOW.DE has a market cap of 2.7B. Regarding current trading prices, MSF.DE is priced at €364.90, while SOW.DE trades at €37.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 25.11, whereas SOW.DE's P/E ratio is 161.30. In terms of profitability, MSF.DE's ROE is +0.33%, compared to SOW.DE's ROE of -0.00%. Regarding short-term risk, MSF.DE is more volatile compared to SOW.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MSF.DE.Check SOW.DE's competition here
MSF.DE vs SUSE.DE Comparison May 2026
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 2.7T. In comparison, SUSE.DE has a market cap of 1.9B. Regarding current trading prices, MSF.DE is priced at €364.90, while SUSE.DE trades at €10.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 25.11, whereas SUSE.DE's P/E ratio is -57.32. In terms of profitability, MSF.DE's ROE is +0.33%, compared to SUSE.DE's ROE of -0.02%. Regarding short-term risk, MSF.DE is more volatile compared to SUSE.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MSF.DE.Check SUSE.DE's competition here
MSF.DE vs YSN.DE Comparison May 2026
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 2.7T. In comparison, YSN.DE has a market cap of 1.3B. Regarding current trading prices, MSF.DE is priced at €364.90, while YSN.DE trades at €201.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 25.11, whereas YSN.DE's P/E ratio is 37.67. In terms of profitability, MSF.DE's ROE is +0.33%, compared to YSN.DE's ROE of +0.22%. Regarding short-term risk, MSF.DE is less volatile compared to YSN.DE. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check YSN.DE's competition here
MSF.DE vs NFN.DE Comparison May 2026
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 2.7T. In comparison, NFN.DE has a market cap of 53.7M. Regarding current trading prices, MSF.DE is priced at €364.90, while NFN.DE trades at €3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 25.11, whereas NFN.DE's P/E ratio is 81.00. In terms of profitability, MSF.DE's ROE is +0.33%, compared to NFN.DE's ROE of +0.05%. Regarding short-term risk, MSF.DE is less volatile compared to NFN.DE. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check NFN.DE's competition here
MSF.DE vs CYR.DE Comparison May 2026
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 2.7T. In comparison, CYR.DE has a market cap of 48.1M. Regarding current trading prices, MSF.DE is priced at €364.90, while CYR.DE trades at €2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 25.11, whereas CYR.DE's P/E ratio is -24.67. In terms of profitability, MSF.DE's ROE is +0.33%, compared to CYR.DE's ROE of -0.02%. Regarding short-term risk, MSF.DE is more volatile compared to CYR.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MSF.DE.Check CYR.DE's competition here
MSF.DE vs R1B.F Comparison May 2026
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 2.7T. In comparison, R1B.F has a market cap of 23M. Regarding current trading prices, MSF.DE is priced at €364.90, while R1B.F trades at €4.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 25.11, whereas R1B.F's P/E ratio is -10.40. In terms of profitability, MSF.DE's ROE is +0.33%, compared to R1B.F's ROE of -0.21%. Regarding short-term risk, MSF.DE is more volatile compared to R1B.F. This indicates potentially higher risk in terms of short-term price fluctuations for MSF.DE.Check R1B.F's competition here
MSF.DE vs INW.DE Comparison May 2026
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 2.7T. In comparison, INW.DE has a market cap of 6.3M. Regarding current trading prices, MSF.DE is priced at €364.90, while INW.DE trades at €3.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 25.11, whereas INW.DE's P/E ratio is 8.86. In terms of profitability, MSF.DE's ROE is +0.33%, compared to INW.DE's ROE of -0.07%. Regarding short-term risk, MSF.DE is more volatile compared to INW.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MSF.DE.Check INW.DE's competition here
MSF.DE vs ABT.DU Comparison May 2026
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 2.7T. In comparison, ABT.DU has a market cap of 4.1M. Regarding current trading prices, MSF.DE is priced at €364.90, while ABT.DU trades at €0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 25.11, whereas ABT.DU's P/E ratio is -20.00. In terms of profitability, MSF.DE's ROE is +0.33%, compared to ABT.DU's ROE of -0.08%. Regarding short-term risk, MSF.DE is more volatile compared to ABT.DU. This indicates potentially higher risk in terms of short-term price fluctuations for MSF.DE.Check ABT.DU's competition here
MSF.DE vs UMDK.DE Comparison May 2026
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 2.7T. In comparison, UMDK.DE has a market cap of 1.8M. Regarding current trading prices, MSF.DE is priced at €364.90, while UMDK.DE trades at €0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 25.11, whereas UMDK.DE's P/E ratio is -0.19. In terms of profitability, MSF.DE's ROE is +0.33%, compared to UMDK.DE's ROE of -0.15%. Regarding short-term risk, MSF.DE is less volatile compared to UMDK.DE. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check UMDK.DE's competition here
MSF.DE vs O5H.DE Comparison May 2026
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 2.7T. In comparison, O5H.DE has a market cap of 400.8K. Regarding current trading prices, MSF.DE is priced at €364.90, while O5H.DE trades at €0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 25.11, whereas O5H.DE's P/E ratio is -0.11. In terms of profitability, MSF.DE's ROE is +0.33%, compared to O5H.DE's ROE of -3.13%. Regarding short-term risk, MSF.DE is less volatile compared to O5H.DE. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check O5H.DE's competition here
MSF.DE vs INW1.DE Comparison May 2026
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 2.7T. In comparison, INW1.DE has a market cap of 0. Regarding current trading prices, MSF.DE is priced at €364.90, while INW1.DE trades at €2.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 25.11, whereas INW1.DE's P/E ratio is -61.94. In terms of profitability, MSF.DE's ROE is +0.33%, compared to INW1.DE's ROE of -0.07%. Regarding short-term risk, MSF.DE is less volatile compared to INW1.DE. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check INW1.DE's competition here
MSF.DE vs 50C.MU Comparison May 2026
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 2.7T. In comparison, 50C.MU has a market cap of 0. Regarding current trading prices, MSF.DE is priced at €364.90, while 50C.MU trades at €0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 25.11, whereas 50C.MU's P/E ratio is N/A. In terms of profitability, MSF.DE's ROE is +0.33%, compared to 50C.MU's ROE of N/A. Regarding short-term risk, MSF.DE is less volatile compared to 50C.MU. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check 50C.MU's competition here